PACT PHARMA Trademark

Trademark Overview


On Thursday, May 6, 2021, a trademark application was filed for PACT PHARMA with the United States Patent and Trademark Office. The USPTO has given the PACT PHARMA trademark a serial number of 90692997. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Tuesday, February 27, 2024. This trademark is owned by PACT Pharma, Inc.. The PACT PHARMA trademark is filed in the Pharmaceutical Products, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Bio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse

pharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse

design of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
pact pharma

General Information


Serial Number90692997
Word MarkPACT PHARMA
Filing DateThursday, May 6, 2021
Status711 - CANCELLED - SECTION 7
Status DateTuesday, February 27, 2024
Registration Number6629196
Registration DateTuesday, January 25, 2022
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesBio-manufacturing for others, namely, manufacturing of adoptive cell and personalized adoptive cell therapies; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
Description of MarkThe mark consists of the word PACT in the color white with a line split between the letter T on a background that is an irregular circular shape and 3 colors. The first color closest to the word PACT is dark blue, the center color is light blue, and the last color is green. The word PHARMA is to the right of the irregular circular shape in the color white and lowercase characters. The irregular circular shape is shaped like a T-cell. The black background is not part of the mark.
Goods and Servicespharmaceutical preparations and substances for the treatment of genetic diseases, immunological diseases and cancer; personalized cell therapies for medical use for the treatment of cancer; biological preparations for medical purposes, namely, in the field of personalized cell therapies for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations; pharmaceuticals, namely, immunotherapies for the treatment of cancer; oncological preparations, namely, pharmaceutical products for the detection and treatment of cancer; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the treatment of cancer and oncological conditions; none of the foregoing for use in connection with patient self-management, pain management or substance misuse
Indication of Colors claimedThe color(s) White, dark blue, light blue and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMA"
Goods and Servicesdesign of personalized adoptive cell therapies for others; none of the foregoing for use in connection with patient self-management, pain management or substance misuse

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateTuesday, February 27, 2024
Primary Code005
First Use Anywhere DateWednesday, June 21, 2017
First Use In Commerce DateWednesday, June 21, 2017

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateTuesday, February 27, 2024
Primary Code040
First Use Anywhere DateWednesday, June 21, 2017
First Use In Commerce DateWednesday, June 21, 2017

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateTuesday, February 27, 2024
Primary Code042
First Use Anywhere DateWednesday, June 21, 2017
First Use In Commerce DateWednesday, June 21, 2017

Trademark Owner History


Party NamePACT Pharma, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NamePACT Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NamePACT Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, February 28, 2024NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Tuesday, February 27, 2024CANCELLED SECTION 7-TOTAL
Friday, June 16, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, February 21, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, June 16, 2023TEAS SECTION 7 SURRENDER RECEIVED
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 27, 2021NON-FINAL ACTION E-MAILED
Monday, September 27, 2021NON-FINAL ACTION WRITTEN
Monday, September 27, 2021ASSIGNED TO EXAMINER
Tuesday, August 10, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, August 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 10, 2021NEW APPLICATION ENTERED